Marie Ange Mouret-Reynier

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort

Amélie Darlix, G. Louvel, Julien Fraisse et al. · British Journal of Cancer · 2019 · 221 citations · Full text

Medicine, Oncology, Breast Oncology +15

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

Élise Deluche, Alison Antoine, Thomas Bachelot et al. · European Journal of Cancer · 2020 · 192 citations

Medicine, Gynecology, Oncology +17

Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse

Émilie Thivat, Sophie Thérondel, Olivier Lapirot et al. · BMC Cancer · 2010 · 128 citations · Full text

Medicine, Oncology, Breast Oncology +11

Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

Philipp Harter, Marie Ange Mouret-Reynier, Sandro Pignata et al. · Gynecologic Oncology · 2021 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort

Amélie Darlix, G. Louvel, Julien Fraisse et al. · European Journal of Cancer · 2019 · 54 citations · Full text

Medicine, Oncology, Surgery +13